6 terminated. 6 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Terminated 6 |
| Phase 2 | 1 | Terminated 1 |
Follow Agranulocytosis: new trials by email Literature Review of Agranulocytosis trials Research Report on Agranulocytosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Early Stoppage Versus Continuation of Antimicrobial Therapy in Low Risk Pediatric Cancer Patients With Febrile Neutropenia, Before Recovery of Counts: -DALFEN Study stoppage of antibiotics, amoxycillin/clavulanic acid, levofloxacin - Neutropenia, Febrile, Pediatric Cancer | Phase 3 | Terminated | All India Institute of Medical Sciences | 142 | 2017-01-01 | 2019-02-01 |
| Controling Intestinal Colonization With Extended Spectrum ß-Lactamase Producing Enterobacteriaceae ESBL-E ESBL eradication regimen, Placebo ESBL eradication - Cancer | Phase 2 / Phase 3 | Terminated | Maria J.G.T. Vehreschild | 29 | 2014-01-01 | 2017-05-08 |
| Daptomycin Versus Placebo in Patients With Neutropenia and Fever Daptomycin, Saline Placebo - Febrile Neutropenia | Phase 3 | Terminated | University of Rochester | 36 | 2011-04-01 | 2014-04-10 |
| An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Serious Fungal Infection Due To Candida In Patients With A Dysfunctional Immune System Active Anidulafungin, Active Caspofungin - Fungemia, Neutropenia | Phase 3 | Terminated | Pfizer | 21 | 2009-08-01 | 2012-12-20 |
| A Study of Ceftobiprole in Patients With Fever and Neutropenia. Ceftobiprole Medocaril, Cefepime with or without vancomycin - Fever, Neutropenia | Phase 3 | Terminated | Basilea Pharmaceutica | 2 | 2007-10-01 | 2012-08-01 |
| Low-risk Fever and Neutropenia in Children With Cancer: Safety and Efficacy of Oral Antibiotics in an Outpatient Setting ciprofloxacin and amoxicillin, Outpatient management, i.v. antibiotics - Fever, Neutropenia | Phase 3 | Terminated | Swiss Pediatric Oncology Group | 70 | 2004-01-01 | 2020-11-02 |
Neutropenia (4) · Neoplasms (3) · Febrile Neutropenia (2) · Fever (2) · Candidemia (1) · Candidiasis (1) · Candidiasis, Invasive (1) · Fungemia (1) · Gram-Positive Bacterial Infections (1) · Mycoses (1) · Pseudomonas Infections (1) · Sepsis (1) · Torulopsis (1)
Cytopenia (6) · Hematologic Diseases (6) · Hemic and Lymphatic Diseases (6) · Leukocyte Disorders (6) · Leukopenia (6) · Pathological Conditions, Signs and Symptoms (4) · Infections (3) · Bacterial Infections and Mycoses (2) · Body Temperature Changes (2) · Inflammation (2) · Neutropenia (2) · Pathologic Processes (2) · Signs and Symptoms (2) · Systemic Inflammatory Response Syndrome (2)
Amoxicillin (1) · Amoxicillin-Potassium Clavulanate Combination (1) · Cefepime (1) · Ciprofloxacin (1) · Colistin (1) · Daptomycin (1) · Gentamicins (1) · Levofloxacin (1) · Vancomycin (1) · ceftobiprole medocaril (1)
All India Institute of Medical Sciences (1) · Basilea Pharmaceutica (1) · Maria J.G.T. Vehreschild (1) · Pfizer (1) · Swiss Pediatric Oncology Group (1) · University of Rochester (1)
Germany (2) · Bosnia and Herzegovina (1) · France (1) · India (1) · Italy (1) · Netherlands (1) · Poland (1) · Russia (1) · Slovakia (1) · Switzerland (1) · United States (1)
Arne Simon, MD (1) · Christoph Aebi, MD (1) · David Nadal, MD (1) · Felix Niggli, MD (1) · Hulya Ozsahin, MD (1) · Maja Beck-Popovic, MD (1) · Maria J Vehreschild, MD (1) · Nicole Bodmer, MD (1) · Robert F Betts, MD (1) · Roland A Ammann, MD (1) · Sameer Bakhshi, Professor (1) · Thomas Kuehne, MD (1)
PMID 20231680, PMID 21394050, PMID 21837771, PMID 22271702, PMID 24618935, PMID 25020130, PMID 26619462, PMID 28459966, PMID 28597967, PMID 31220256, PMID 33891293